.png "Janet Woodcock"){kind=small}
Robert Califf
Search results
Feb 17, 2022 · Janet Woodcock is the FDA’s Principal Deputy Commissioner. In this role she works closely with the Commissioner of Food and Drugs to develop and implement key public health initiatives and...
Woodcock joined the U.S. Food and Drug Administration (FDA) in 1986, as the Director of the Division of Biological Investigational New Drugs in the Center for Biologics Evaluation and Research (CBER). As of September, 1990, she became Acting Deputy Director of CBER.
- Roger Miller
- Robert Califf
Nov 17, 2023 · WOODCOCK SET TO RETIRE — Longtime FDA regulator Janet Woodcock, who has worked at the agency since 1986, plans to retire in early 2024, FDA Commissioner Robert Califf told agency staff...
Nov 16, 2023 · WASHINGTON, Nov 16 (Reuters) - U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic...
This Wednesday will be Dr. Janet Woodcock’s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She’s been called one of the most powerful and influential drug regulators worldwide. Last Thursday, Focus sat down with Woodcock in her office at FDA’s White Oak campus, where she reflected ...
Jan 30, 2024 · FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next. By Sarah Owermohle. Reprints. Janet Woodcock, the FDA's principal deputy commissioner Chip...
People also ask
Will FDA regulator Janet Woodcock retire in 2024?
When did Dr Woodcock become FDA Deputy Commissioner?
Why did Elizabeth Woodcock criticize Sarepta Therapeutics?
